Post by
abcdfish on Dec 03, 2020 7:43am
New press release Pre-presentation.
https://www.imv-inc.com/news-events/press-releases/detail/671/imvs-survivin-targeted-t-cell-therapy-shows-durable
Comment by
casher on Dec 03, 2020 9:08am
this is great news! New ovarian cancer treatment on the way. Great clinical benefit, LONG duration of response and very limited side effects on one of the most difficult cancers to treat. There will be formalizing a plan to approach the FDA and pivotal trial expected in Q2 Highly encourage anyone interested to review the webcast
Comment by
alphaseeking001 on Dec 03, 2020 9:52am
Sorry, reposted without my comment. I missed the webcast. Any positive commentary from the analysts? Any concerns from any of them? The WF fellow has been hit or miss with us as us long's know!
Comment by
Hideaway on Dec 03, 2020 10:06am
Why are we down 5 cents with 117k traded on us exchange?This appeared to be great news but obviously I missed something.
Comment by
FastFF on Dec 03, 2020 10:15am
Up now. Doesn't seem lots of people wanted to get up that early and listen - probably will take a bit to filter in. Definately another step in right direction.